Paeoniflorin inhibits inflammatory responses in mice with allergic contact dermatitis by regulating the balance between inflammatory and anti-inflammatory cytokines

Inflammation Research

Volumn 62, Issue 12, 2013, Pages 1035-1044

  Wang, Chun ^a   Yuan, Jun ^a   Wu, Hua Xun ^a   Chang, Yan ^a   Wang, Qing Tong ^a   Wu, Yu Jing ^a   Liu, Li Hua ^a   Wei, Wei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Allergic contact dermatitis; Interleukin 17; Interleukin 10; Interleukin 2; Interleukin 4; Paeoniflorin

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; PAEONIFLORIN; PREDNISONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MOUSE; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; SKIN ALLERGY; SKIN SWELLING; THYMOCYTE;

ANIMALS; ANIMALS, OUTBRED STRAINS; ANTI-INFLAMMATORY AGENTS; BENZOATES; BRIDGED COMPOUNDS; CYTOKINES; DERMATITIS, ALLERGIC CONTACT; DINITROCHLOROBENZENE; GLUCOSIDES; IRRITANTS; MALE; MICE; SKIN; SPLEEN; THYMUS GLAND;

EID: 84889093549     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0662-8     Document Type: Article

References (44)

1. Popov A, Mirkov I, Miljković D, et al. Contact allergic response to dinitrochlorobenzene (DNCB) in rats: insight from sensitization phase. Immunobiology. 2011;216:763-70.
2. Zhang EY, Chen AY, Zhu BT. Mechanism of dinitrochlorobenzene-induced dermatitis in mice: role of specific antibodies in pathogenesis. PLoS One. 2009;4:e7703.
3. Akhtar N, Satyam A, Anand V, et al. Dysregulation of T(H) type cytokines in the patients of Parthenium induced contact dermatitis. Clin Chim Acta. 2010;411:2024-8.
4. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type1and 2 lineages. Nat Immunol. 2005;6:1123-32.
5. Wang B, Zhuang L, Fujisawa H, et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol. 1999;162:277-83.
6. Wang WJ, Hao CF, Qu QL, et al. The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage. Hum Reprod. 2010;25:2591-6.
7. Longhi MS, Liberal R, Holder B, et al. Inhibition of Interleukin-17 Promotes Differentiation of CD25(-) Cells Into Stable T Regulatory Cells in Patients With Autoimmune Hepatitis. Gastroenterology. 2012;142:1526-35.e6.
8. Zheng YQ, Wei W, Zhu L, Liu JX. Effects and mechanisms of Paeoniflorin, a bioactive glucoside from paeony root, on adjuvant arthritis in rats. Inflamm Res. 2007;56:182-8.
9. Li X, Shen J, Zhong Z, et al. Paeoniflorin: a monomer from traditional Chinese medical herb ameliorates Schistosoma japonicum egg-induced hepatic fibrosis in mice. J Parasitol. 2009;95:1520-4.
10. Lee JY, Kang HS, Park BE, et al. Inhibitory effects of Geijigajakyak-Tang on trinitrobenzene sulfonic acid -induced colitis. J Ethnopharmacol. 2009;126:244-51.
11. Min WQ, Wei Q, Li HY, et al. A clinical study of total glucosides paeony in the treatment of rheumatoid arthritis: a multi-center trial. Chin J Rheumatol. 2005;9:487-91.
12. Zhang L, Dong Y, Sun Y, et al. Role of four major components in the effect of Si-Ni-San, a traditional Chinese prescription, against contact sensitivity in mice. J Pharm Pharmacol. 2006;58:1257-64.
13. Sun Y, Dong Y, Jiang HJ, et al. Dissection of the role of paeoniflorin in the traditional Chinese medicinal formula Si-Ni-San against contact dermatitis in mice. Life Sci. 2009;84:337-44.
14. Liu ZQ, Jiang ZH, Chan K, et al. Pharmacokinetic interaction of paeoniflorin and sinomenine: pharmacokinetic parameters and tissue distribution characteristics in rats and protein binding ability in vitro. J Pharmacol Sci. 2005;99:381-91.
15. Yuan XY, Liu W, Zhang P, et al. Effects and mechanisms of aloperine on 2, 4-dinitrofluorobenzene -induced allergic contact dermatitis in BALB/c mice. Eur J Pharmacol. 2010;629:147-52.
16. Germolec DR, Nyska A, Kashon M, et al. Extended histopathology in immunotoxicity testing: interlaboratory validation studies. Toxicol Sci. 2004;78:107-15.
17. Zhang LL, Wei W, Yan SX, et al. Therapeutic effects of glucosides of Cheanomeles speciosa on collagen-induced arthritis in mice. Acta Pharmacol Sin. 2004;25:1495-501.
18. Liu K, Xu Q. Roxithromycin inhibits the effector phase of delayed-type hypersensitivity. Int Immunopharmacol. 2008;8:126-31.
19. Akhtar N, Verma KK, Sharma A. Study of pro- and anti-inflammatory cytokine profile in the patients with parthenium dermatitis. Contact Dermatitis. 2010;63:203-8.
20. Fontenot JD, Rasmussen JP, Gavin MA. Rudensky AY.A function for interleukin 2 in Foxp3- expressing regulatory T cells. Nat Immunol. 2005;6:1142-51.
21. Cork MJ, Keohane SG, Gawkrodger DJ, et al. Cytokine dermatosis: reactivation of eczema during interleukin-2 infusion. Br J Dermatol. 1997;136:644-5.
22. Xu H, DiIulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma- producing (Tc1) effector CD8+ T cells and interleukin (IL) 4/IL-10-producing (Th2) negative regulatory CD4+ T cells. Exp Med. 1996;183:1001-12.
23. Takeshita K, Yamasaki T, Akira S, et al. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int Immunol. 2004;16(5):685-95.
24. Nakae S, Komiyama Y, Nambu A, et al. Antigen-specific T cell sensitization is impaired in IL-17- deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 2002;17:375-87.
25. He D, Wu L, Kim HK, et al. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J Immunol. 2006;177:6852-8.
26. Antonysamy MA, Fanslow WC, Fu F, et al. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol. 1999;162:577-84.
27. Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol. 1999;162:494-502.
28. Albanesi C, Scarponi C, Cavani A, et al. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4 induced activation of human keratinocytes. J Invest Dermatol. 2000;115:81-7.
29. Asarch A, Barak O, Loo DS, Gottlieb AB. Th17 cells: a new therapeutic target in inflammatory dermatoses. J Dermatolog Treat. 2008;19:318-26.
30. He D, Wu L, Kim HK, et al. IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses. J Immunol. 2009;183:1463-70.
31. Minang JT, Areström I, Zuber B, et al. Nickel-induced IL-10 down-regulates Th1- but not Th2-type cytokine responses to the contact allergen nickel. Clin Exp Immunol. 2006;143:494-502.
32. Zhou H, Bian D, Jiao X, et al. Paeoniflorin protects against lipopolysaccharide-induced acute lung injury in mice by alleviating inflammatory cell infiltration and microvascular permeability. Inflamm Res. 2011;60:981-90.
33. Wu H, Wei W, Song L, et al. Paeoniflorin induced immune tolerance of mesenteric lymph node lymphocytes via enhancing beta 2-adrenergic receptor desensitization in rats with adjuvant arthritis. Int Immunopharmacol. 2007;7:662-73.
34. Cao W, Zhang W, Liu J, et al. Paeoniflorin improves survival in LPS-challenged mice through the suppression of TNF-α and IL-1β release and augmentation of IL-10 production. Int Immunopharmacol. 2011;11:172-8.
35. Tsuboi H, Hossain K, Akhand AA, et al. Paeoniflorin induces apoptosis of lymphocytes through a redox-linked mechanism. J Cell Biochem. 2004;93:162-72.
36. Zhang L, Zhang S. Modulating Bcl-2 family proteins and caspase-3 in induction of apoptosis by paeoniflorin in human cervical cancer cells. Phytother Res. 2011;25:1551-7.
37. Jin B, Sun T, Yu XH, et al. The effects of TLR activation on T-cell development and differentiation. Clin Dev Immunol. 2012;2012:836485. doi: 10.1155/2012/836485 (Epub 2012 Jun 7).
38. Yin Y, Sun Y, Gu L, et al. Jaceosidin inhibits contact hypersensitivity in mice via down-regulating IFN-γ/STAT1/T-bet signaling in T cells. Eur J Pharmacol. 2011;651:205-11.
39. Rácz E, Kurek D, Kant M, et al. GATA3 expression is decreased in psoriasis and during epidermal regeneration; induction by narrow-band UVB and IL-4. PLoS One. 2011;6:e19806.
40. Weise C, Zhu Y, Ernst D, et al. Oral administration of Escherichia coli Nissle 1917 prevents allergen-induced dermatitis in mice. Exp Dermatol. 2011;20:805-9.
41. Martiniuk F, Lee DS, Gaspari A, et al. Expression of CD70 and the TH17 transcription factor ROR gammaT in human contact dermatitis. J Drugs Dermatol. 2008;7:956-60.
42. Lin J, Xiao L, Ouyang G, et al. Total glucosides of paeony inhibits Th1/Th17 cells via decreasing dendritic cells activation in rheumatoid arthritis. Cell Immunol. 2012;280:156-63.
43. Wang K, Wu YG, Su J, et al. Total glucosides of paeony regulates JAK2/STAT3 activation and macrophage proliferation in diabetic rat kidneys. Am J Chin Med. 2012;40:521-36.
44. Zhao M, Liang GP, Tang MN, et al. Total glucosides of paeony induces regulatory CD4(+)CD25(+) T cells by increasing Foxp3 demethylation in lupus CD4(+) T cells. Clin Immunol. 2012;143:180-7.